Skip to content

Clinical trials

Withdrawn Fatty Liver trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Status: Withdrawn Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20141
20161
20171
20192
20201
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fibronostics USA, Inc1
Gyongyi Szabo1
Medical College of Wisconsin1
Methodist Health System1
ProgenaBiome1
Shriners Hospitals for Children1
University of Maryland, Baltimore1
University of Missouri-Columbia1
Vanderbilt University1
Wen-Chih Wu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver10
Non-alcoholic Fatty Liver Disease5
Diabetes Mellitus2
Fibrosis2
Body Weight Changes1
Burns1
Diabetes Mellitus, Type 21
Glucose Intolerance1
Heart Failure1
Hypertension, Pulmonary1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.